Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Achievement and ABL1[original query]
Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.
Leukemia research 2016 Sep 51 11-18.
Miyamura Koichi, Miyamoto Toshihiro, Tanimoto Mitsune, Yamamoto Kazuhito, Kimura Shinya, Kawaguchi Tatsuya, Matsumura Itaru, Hata Tomoko, Tsurumi Hisashi, Saito Shigeki, Hino Masayuki, Tadokoro Seiji, Meguro Kuniaki, Hyodo Hideo, Yamamoto Masahide, Kubo Kohmei, Tsukada Junichi, Kondo Midori, Aoki Makoto, Okada Hikaru, Yanada Masamitsu, Ohyashiki Kazuma, Taniwaki Masafu
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Journal of experimental & clinical cancer research : CR 2017 Apr 36 (1): 55.
Jaruskova Monika, Curik Nikola, Hercog Rajna, Polivkova Vaclava, Motlova Eliska, Benes Vladimir, Klamova Hana, Pecherkova Pavla, Belohlavkova Petra, Vrbacky Filip, Machova Polakova Kateri
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia 2019 Feb .
Yoo Hea-Lyun, Kim Soo-Hyun, Choi Soo-Young, Lee Sung-Eun, Kim Dong-Wo
[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways].
Terapevticheskii arkhiv 2020 12 92 (7): 31-42.
Zarubina K I, Parovichnikova E N, Surin V L, Pshenichnikova O S, Gavrilina O A, Isinova G A, Troitskaia V V, Sokolov A N, Gal'tseva I V, Kapranov N M, Davydova I O, Obukhova T N, Sudarikov A B, Savchenko V
Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients.
Leukemia research 2021 Oct 111 106728.
Park Hyunkyung, Kim Inho, Kim Hyeong-Joon, Shin Dong-Yeop, Lee Sung-Yeoun, Kwon Oh-Hyung, Kim Dae-Young, Lee Kyoo-Hyung, Ahn Jae-Sook, Park Jinny, Sohn Sang-Kyun, Lee Jeong-Ok, Cheong June-Won, Kim Kyoung Ha, Kim Hoon-Gu, Kim Hawk, Lee Yoo Jin, Nam Seung-Hyun, Do Young Rok, Park Sang-Gon, Park Seong Kyu, Bae Sung Hwa, Song Hun Ho, Oh Doyeun, Jung Chul Won, Park Seonya
Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR?ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study.
Cancers 2022 12 14 (23): .
Hu Shiwei, Chen Dan, Xu Xiaofei, Zhang Lan, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Jin Jie, Huang Ji
Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia.
Leukemia research 2025 1 149 107644.
María Belén Fontecha, María Del Rosario Anadón, Inés María Martínez Lahitou, Natalia Weich, Raquel Bengió, Beatriz Moiraghi, Irene Larripa, Ariela Freya Fund
TOP